What is the equity of Genedrive this year?
Genedrive has equity of 2.04 M GBP this year.
Genedrive Equity 2024
Genedrive Equity
2.04 M GBP
Ticker
GDR.L
ISIN
GB00B1VKB244
WKN
A0ML2T
In 2024, Genedrive's equity was 2.04 M GBP, a -63.63% increase from the 5.61 M GBP equity in the previous year.
Genedrive Aktienanalyse
What does Genedrive do?
Genedrive PLC is a biomedical company based in Manchester, United Kingdom, specializing in the development of innovative diagnostic tests for infectious diseases and cancer. The company was founded in 2007 under the name Epistem Limited and went public in 2013. The business model of Genedrive involves developing and distributing innovative molecular diagnostic tests for diseases worldwide. The company's main goal is to change the way infectious diseases and cancer are diagnosed and treated by offering rapid, accurate, and cost-effective tests. The company has two main divisions: Genprobe and Instruments. Under Genprobe, various in vitro diagnostic tests for infectious diseases and diseases of the human immune system, including tuberculosis, hepatitis C, hepatitis B, HIV, and others, are offered. Under Instruments, Genedrive offers PCR instruments used for analyzing samples for DNA and RNA sequences. Some of Genedrive's key products include: - Genedrive HCV-ID Testkit: A test kit for identifying and quantifying hepatitis C viruses (HCV) in human blood samples. The test provides results within 90 minutes and has high accuracy. - Genedrive MT-RNR1 Testkit: A test kit for the rapid diagnosis of tuberculosis (TB), one of the most common infectious diseases worldwide. The test utilizes PCR technology and provides results within 90 minutes. - Genedrive Genedrive 96: An instrument for simultaneous analysis of up to 96 PCR samples. The system offers high accuracy and precision in analyzing RNA and DNA sequences. The company collaborates closely with leading research institutions and health organizations worldwide to improve its products and develop new tests. Genedrive has formed partnerships with the British government, the US Department of Defense, and other institutions. In recent years, the company has made significant progress in developing new diagnostic tests for infectious diseases and cancer. For example, Genedrive recently signed an agreement with the Foundation for Innovative New Diagnostics (FIND) to develop a molecular test for the Ebola virus. The company also has a pipeline of projects, including tests for COVID-19 and antibiotic resistance. Despite Genedrive's success, the company remains committed to innovation and research in order to transform the diagnostics industry and improve the health of people worldwide. Genedrive is expected to continue playing an important role in the fight against infectious diseases and cancer in the future. Genedrive ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Genedrive's Equity
Genedrive's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Genedrive's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Genedrive's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Genedrive's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Genedrive’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Genedrive stock
What was the equity of Genedrive compared to the previous year?
The equity of Genedrive has increased/decreased by -63.63% decreased compared to the previous year.
What impact does a high equity have on investors of Genedrive?
A high equity is advantageous for investors of Genedrive as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Genedrive?
A low equity can be a risk for investors of Genedrive, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Genedrive affect the company?
An increase in equity of Genedrive can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Genedrive affect the company?
A reduction in equity of Genedrive can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Genedrive?
Some factors that can affect the equity of Genedrive include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Genedrive so important for investors?
The equity of Genedrive is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Genedrive take to change the equity?
To change equity, Genedrive can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Genedrive pay?
Over the past 12 months, Genedrive paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genedrive is expected to pay a dividend of 0 GBP.
What is the dividend yield of Genedrive?
The current dividend yield of Genedrive is .
When does Genedrive pay dividends?
Genedrive pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genedrive?
Genedrive paid dividends every year for the past 0 years.
What is the dividend of Genedrive?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genedrive located?
Genedrive is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genedrive kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genedrive from 9/17/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Genedrive pay the last dividend?
The last dividend was paid out on 9/17/2024.
What was the dividend of Genedrive in the year 2023?
In the year 2023, Genedrive distributed 0 GBP as dividends.
In which currency does Genedrive pay out the dividend?
The dividends of Genedrive are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Genedrive
Our stock analysis for Genedrive Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genedrive Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
